Fig. 6From: Isotalatizidine, a C19-diterpenoid alkaloid, attenuates chronic neuropathic pain through stimulating ERK/CREB signaling pathway-mediated microglial dynorphin A expressionProposed analgesic mechanism of isotalatizidine for ERK/CREB signal pathway-induced expression of dynorphin A in spinal microgliaBack to article page